Position in ADCT
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$55,496
-$20 QoQ
Shares Held
14,799
-5.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $26,613,103 across 27 Drug Manufacturers - Specialty & Generic names. ADCT ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
99,300 | $11,738,253 | |
| 2 | VTRS |
Viatris Inc
|
229,555 | $3,101,288 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,687 | $2,186,317 | |
| 4 | ALKS |
Alkermes plc.
|
32,729 | $1,157,297 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
8,514 | $1,121,634 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
12,135 | $920,439 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
38,617 | $801,688 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,509 | $747,034 |
All Filings in ADCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,496 | 14,799 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $55,516 | 15,727 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $49,552 | 12,388 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $39,811 | 14,855 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $24,823 | 17,605 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $45,572 | 22,901 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,402 | 15,366 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||